NCT00331825View on ClinicalTrials.gov

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2000

Study Completion Date

July 31, 2003

Conditions

SchizophreniaExtrapyramidal Syndrome

Interventions

DRUG

Risperidone and Olanzapine

Trial Locations (1)

330

Taoyuan Mental Hospital, Taoyuan District

All Listed Sponsors

collaborator

Department of Health

AMBIG

lead

Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan

OTHER_GOV

NCT00331825 - Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism | Biotech Hunter | Biotech Hunter